Compounds > cyclosporine

cyclosporine and Shock

cyclosporine has been researched along with Shock in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Gandhi, M; Rai, E; Shirley, A; Suda, NK1
Lenert, A; Yao, Q1
Abramowicz, D; Delvaux, A; Donckier, V; Fiers, W; Flament, V; Gérard, C; Leo, O; Vandenabeele, P; Velu, T; Wissing, M1
Borlongan, CV; Fujisaki, T; Watanabe, S1
Altavilla, D; Arlotta, M; Bova, A; Campo, GM; Caputi, AP; Deodato, B; Ferlito, M; Minutoli, L; Quartarone, C; Saitta, A; Sardella, A; Squadrito, F; Squadrito, G; Urna, G1
Altavilla, D; Bazzani, C; Bertolini, A; Galeano, M; Guarini, S; Saitta, A; Santamaria, LB; Squadrito, F; Squadrito, G; Venuti, FS1

Other Studies

6 other study(ies) available for cyclosporine and Shock

ArticleYear
Massive gingival bleed: a rare manifestation of cyclosporine toxicity.
    BMJ case reports, 2020, Dec-22, Volume: 13, Issue:12

    Topics: Blood Transfusion; Child; Cyclosporine; Fatal Outcome; Female; Gingival Hemorrhage; Gingival Hyperplasia; Heart Arrest; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Intubation, Intratracheal; Pancytopenia; Severity of Illness Index; Shock; Thalassemia; Transfusion-Related Acute Lung Injury

2020
Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Seminars in arthritis and rheumatism, 2016, Volume: 45, Issue:6

    Topics: Adult; Cyclosporine; Disseminated Intravascular Coagulation; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Liver Diseases; Lung Diseases; Macrophage Activation Syndrome; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Serositis; Shock; Still's Disease, Adult-Onset; Young Adult

2016
Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10.
    Transplantation, 1994, May-27, Volume: 57, Issue:10

    Topics: Animals; Antibodies, Monoclonal; CD3 Complex; Cyclosporine; Female; Interferon-gamma; Interleukin-10; Interleukin-6; Mice; Mice, Inbred BALB C; Secretory Rate; Shock; T-Lymphocytes; Tumor Necrosis Factor-alpha

1994
Chronic administration of cyclosporine A does not impair memory retention in rats.
    Neuroreport, 1997, Feb-10, Volume: 8, Issue:3

    Topics: Animals; Avoidance Learning; Cyclosporine; Female; Immunosuppressive Agents; Memory; Neuroprotective Agents; Rats; Rats, Wistar; Reaction Time; Shock

1997
Protective effects of cyclosporin-A in splanchnic artery occlusion shock.
    British journal of pharmacology, 2000, Volume: 130, Issue:2

    Topics: Animals; Aorta; Arterial Occlusive Diseases; Blood Pressure; Cyclosporine; Enzyme Activation; Immunosuppressive Agents; Male; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Sprague-Dawley; Shock; Splanchnic Circulation; Tumor Necrosis Factor-alpha

2000
Nuclear factor-kappaB as a target of cyclosporin in acute hypovolemic hemorrhagic shock.
    Cardiovascular research, 2001, Volume: 52, Issue:1

    Topics: Animals; Aorta; Blotting, Western; Cells, Cultured; Cyclosporine; Cytoplasm; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Hydrogen Peroxide; I-kappa B Proteins; Immunosuppressive Agents; In Vitro Techniques; Liver; Macrophage Activation; Macrophages, Peritoneal; Male; Models, Animal; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylephrine; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shock; Tetradecanoylphorbol Acetate; Time Factors; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents

2001